Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2004
08/10/2004US6774281 By transforming a plant with a polynucleotide sequence comprising a pathogen inducible promoter which regulates the expression of a plant signal transduction protein which when expressed gives rise to a hypersensitive response in plants
08/10/2004US6774279 Use of FLP recombinase in mice
08/10/2004US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif)
08/10/2004US6774224 ULBP DNA and polypeptides
08/10/2004US6774222 Comprises a nucleic acid having at least two protein binding sites that cannot be simultaneously occupied by their cognate binding protein
08/10/2004US6774220 Compounds having lectinic properties and their biological applications
08/10/2004US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation
08/10/2004US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders
08/10/2004US6774214 Monocyte-derived homolog of FDF03 protein
08/10/2004US6774210 Anti-freeze protein derived from lichen, especially umbilicaria antarctica
08/10/2004US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
08/10/2004US6774119 Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
08/10/2004US6774118 Therapeutic use of CIS-element decoys in vivo
08/10/2004US6774116 Prodrugs via acylation with cinnamate
08/10/2004US6774107 Protein for blocking platelet adhesion
08/10/2004US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI
08/10/2004US6774105 Methods of using latent TGF-β binding proteins
08/10/2004US6774082 Composition for use in the separation of preferential biopolymers from sample
08/10/2004US6773920 Delivery of functional protein sequences by translocating polypeptides
08/10/2004US6773919 Transcription enhancers such as serine protease inhibitor-growth hormone responsive element
08/10/2004US6773917 For enhancing synthesis of hydroxyvaleric acid-hydroxybutyric acid coploymers; threonine deaminases
08/10/2004US6773915 Detecting antibodies; culture product
08/10/2004US6773914 PiggyBac transformation system
08/10/2004US6773913 Device and process for purifying vectors
08/10/2004US6773912 Lantibiotic
08/10/2004US6773910 Method of preparing (S)- or (R) -3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid
08/10/2004US6773909 Concentration and lysis of adenovirus-infected cells in a single unit operation
08/10/2004US6773908 From open reading frames; vaccines
08/10/2004US6773907 Amino acid in the active site loop (b) region from positions 95 to 103. the variant subtilases of the present invention exhibit improved wash performance in a detergent in comparison to its parent enzyme
08/10/2004US6773905 Methylomonas nuclelotide sequences coding fructose bisphosphate aldolase (ffbpa) and 2-keto-3-deoxy-6-phosphogluconate aldolase (kdpga) for conversion of hexose sugars into 3-carbon metabolites
08/10/2004US6773901 PCR primers and a method for deciding a base sequence thereof regarding adenylation
08/10/2004US6773900 End selection in directed evolution
08/10/2004US6773899 Generating preferential polypeptide; obtain cells, incubate with expression vector containing preferential gene, express vector, recover polypeptide
08/10/2004US6773897 Monitoring response of cells to antitumor agents; obbtain cells, recover nucleotide sequences, incubate with antitumor agent, monitor methylation of nucleotide sequences compare to control
08/10/2004US6773887 Annealing primer and complementary dna to form hybrid; separating then extending chain; biochemical immobilization
08/10/2004US6773886 Binary encoded sequence tags
08/10/2004US6773884 Nanoparticles having oligonucleotides attached thereto and uses therefor
08/10/2004US6773882 Polynucleotide probes for detection and quantitation of candida species
08/10/2004US6773881 By modulating vascular endothelial growth factor (vegf)
08/10/2004US6773879 Recovering plant nucleotide sequences from sample; obtain plant sample, extract nucleotide sequences, digest, perform genome subtraction, screen for polymorphic sequences
08/10/2004US6773878 For therapy/drug screening
08/10/2004US6773710 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
08/10/2004US6773709 Chicken embryo lethal (CELO) virus
08/10/2004US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections
08/10/2004US6773701 Expression enhancer for protein synthesis inhibitory genes
08/10/2004CA2260365C Differentiation-suppressive polypeptide
08/10/2004CA2243985C Thermostable dna polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes
08/10/2004CA2202639C Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins or vaccinating active principles
08/10/2004CA2145388C Method of controlling polypeptide production in bacteria
08/10/2004CA2129101C Synthetic haemophilus influenzae conjugate vaccine
08/10/2004CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72
08/10/2004CA2090904C Dna detection method
08/09/2004WO2004065591A1 Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals
08/09/2004CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
08/07/2004CA2457220A1 Inhibitors of staphylococcus aureus primary sigma factor and uses thereof
08/07/2004CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders
08/06/2004CA2456483A1 Method for fermentative production of l-methionine
08/05/2004WO2004066183A2 Microrna
08/05/2004WO2004065632A1 Method of judging tumor (cancer) or tumor (cancer) metastasis
08/05/2004WO2004065620A2 Modulation of thyroid hormone receptor interactor 3 expression
08/05/2004WO2004065613A2 Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
08/05/2004WO2004065610A1 METHOD FOR PRODUCING α- L-ASPARTYL-L-PHENYLALANINE-β-ESTER AND METHOD FOR PRODUCING α-L-ASPARTYL-L-PHENYLALANINE-α-METHYL ESTER
08/05/2004WO2004065609A1 Process for acyl-transfer enzyme reactions with acyl- coenzyme a
08/05/2004WO2004065606A2 Glycerol kinase inhibition in transgenic plant cells
08/05/2004WO2004065605A1 β1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF EXAMINING CANCERATION USING THE SAME
08/05/2004WO2004065604A1 Juvenile hormone transmethylase genes and method of using the same
08/05/2004WO2004065603A2 Methods for increasing neisseria protein expression
08/05/2004WO2004065602A1 Method of identifying the epithelial-mesenchymal transition of mesothelial cells (emtmc) and identifying emtmc-modulating compounds, pharmaceutical compositions and use thereof in the diagnosis and treatment of diseases associated with emtmc
08/05/2004WO2004065601A2 Lipophilic derivatives of double-stranded ribonucleic acid
08/05/2004WO2004065600A2 Rna interference by palindromic or modified rna molecules
08/05/2004WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER
08/05/2004WO2004065598A1 Method of screening agent for improving memory and learning ability
08/05/2004WO2004065597A1 A method for cultivating transgenic plants with high virus resistance and the use thereof
08/05/2004WO2004065596A2 Use of the regulatory sequence of the rice gos2 gene for the gene expression in dicotyledonous plants or plant cells
08/05/2004WO2004065594A2 Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof
08/05/2004WO2004065593A1 Recombinant bovine pepsin and pepsinogen produced in prokaryotic and eukaryotic cells
08/05/2004WO2004065587A1 Compositions and processes using sirna, amphipathic compounds and polycations
08/05/2004WO2004065581A2 Transposon-insulator element delivery systems
08/05/2004WO2004065579A2 Modified oligonucleotides for use in gene modulation
08/05/2004WO2004065575A2 Dna compositon and uses thereof
08/05/2004WO2004065574A2 Bacteria for high efficiency cloning
08/05/2004WO2004065571A2 Dna molecules encoding a cotton chitinase and promoter
08/05/2004WO2004065561A2 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
08/05/2004WO2004065558A2 Depletion of endogenous primordial germ cells in avian species
08/05/2004WO2004065557A2 PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF ssDNA VIRUSES
08/05/2004WO2004065555A2 Regulator/promoter for tunable gene expression and metabolite sensing
08/05/2004WO2004065553A2 Method for comprehensive identification of cell lineage specific genes
08/05/2004WO2004065549A2 Small interference rna gene therapy
08/05/2004WO2004065546A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1
08/05/2004WO2004065543A2 Devices and method for recovery of a target molecule from a sample
08/05/2004WO2004065540A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function
08/05/2004WO2004065537A2 Expression cassette with promotors of starch synthesis 3 for the expression of nucleic acids in plant tissue containing starch
08/05/2004WO2004065440A2 Cationic graft-copolymer for non-viral gene delivery vector
08/05/2004WO2004065423A2 Recognition molecules for the treatment and detection of tumours
08/05/2004WO2004065418A1 Anti-pci neutralizing antibody
08/05/2004WO2004065416A2 Synthetic antibody phage libraries
08/05/2004WO2004064868A1 Tarp promoter and uses thereof
08/05/2004WO2004064859A1 A hybrid vector system for use as a vaccine
08/05/2004WO2004064854A1 Method for enhancing learning and memory by suppressing the activity of ncx2 protein
08/05/2004WO2004064782A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides